CymaBay Therapeutics, Inc.
CBAYDelisted Mar 22, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001042074
CymaBay Therapeutics, Inc. was delisted on Mar 22, 2024; its insiders filed their last Form 4 on Mar 22, 2024; 200 institutions reported holding it in 13F filings for Q4 2023, worth $2.71B in total; no superinvestor held it.
13F holders, Q3 2022
Institutional positions in CymaBay Therapeutics, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 100
- −6 vs. Q2 2022
- Shares held
- 62.3M
- −746.8K (−1.2%) vs. Q2 2022
- Total value
- $217.9M
- +$32.0M (+17.2%) vs. Q2 2022
- New holders
- 12
- 18 more added
- Sold out
- 18
- 30 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CBAY on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 1 | $21.1K |
| Q4 2023 | 200 | $2.71B |
| Q3 2023 | 189 | $1.61B |
| Q2 2023 | 151 | $1.02B |
| Q1 2023 | 140 | $774.9M |
| Q4 2022 | 118 | $404.2M |
| Q3 2022 | 100 | $217.9M |
| Q2 2022 | 106 | $185.9M |
| Q1 2022 | 118 | $202.8M |
| Q4 2021 | 113 | $215.7M |
| Q3 2021 | 114 | $169.3M |
| Q2 2021 | 113 | $227.4M |
| Q1 2021 | 130 | $251.7M |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding CymaBay Therapeutics, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −350,000−100.0% | Sold out |
| Pinz Capital Management, LP | 0 | $0 | 0.00% | −231,680−100.0% | Sold out |
| Alpine Global Management, LLC | 0 | $0 | 0.00% | −197,888−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −34,563−100.0% | Sold out |
| Acadian Asset Management LLC | 0 | $0 | 0.00% | −31,827−100.0% | Sold out |
| Myriad Asset Management US LP | 0 | $0 | 0.00% | −30,000−100.0% | Sold out |
| Caption Management, LLC | 0 | $0 | 0.00% | −30,000−100.0% | Sold out |
| Rafferty Asset Management, LLC | 0 | $0 | 0.00% | −27,810−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −23,644−100.0% | Sold out |
| Clear Harbor Asset Management, LLC | 0 | $0 | 0.00% | −15,600−100.0% | Sold out |
| Boothbay Fund Management, LLC | 0 | $0 | 0.00% | −14,479−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −13,535−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −11,000−100.0% | Sold out |
| Vectors Research Management, LLC | 0 | $0 | 0.00% | −6,000−100.0% | Sold out |
| Captrust Financial Advisors | 0 | $0 | 0.00% | −5,628−100.0% | Sold out |
| New York State Common Retirement Fund | 0 | $0 | 0.00% | −584−100.0% | Sold out |
| Howe & Rusling Inc | 0 | $0 | 0.00% | −200−100.0% | Sold out |
| Tradewinds Capital Management, LLC | 0 | $0 | 0.00% | −35−100.0% | Sold out |